Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increased-Dose Abiraterone in CRPC
NCT01637402Phase 2Completed
- Start
- Mar 2013
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Abiraterone Acetate Tablets (I) in castration-resistant prostate cancer (CRPC). Started Mar 2013; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT01637402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637402.